An investor asked on the investor interaction platform: how much NC membrane capacity does your company have at this stage? What are the revenue and net interest rates respectively? When will the capacity expansion be implemented? How much capacity and revenue can be achieved after expansion?
Zhejiangtailin Bioengineering Co.Ltd(300813) ( Zhejiangtailin Bioengineering Co.Ltd(300813) . SZ) said on the investor interaction platform on April 7 that the company’s current NC membrane capacity is small, the subsequent production site expansion and equipment introduction are still in progress, and the specific production time is still uncertain.
